Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 64 results.
User Information
Export Records
  1. 1.   Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy
  2. Mohammad, Saad N; Choi, Yeon Su; Chung, Jee Young; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Yang, Xiaojing; Guo, Wei; Chew, Yap Ching; Kim, Juwan; Baek, Seunggul; Kim, Ik Soo; Fruman, David A; Kwon, Young Jik
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2023, Jan; 354: 91-108.
  1. 2.   Transcriptomic Analysis of Human Podocytes In Vitro: Effects of Differentiation and APOL1 Genotype
  2. Yoshida, Teruhiko; Latt, Khun Zaw; Rosenberg, Avi Z; Shrivastav, Shashi; Heymann, Jurgen; Halushka, Marc K; Winkler,Cheryl; Kopp, Jeffrey B
  3. Kidney International Reports. 2023, Jan; 8(1): 164-178.
  1. 3.   An RNA Repair Operon Regulated by Damaged tRNAs
  2. Hughes,Kevin; Chen,Xinguo; Burroughs, A Maxwell; Aravind, L; Wolin,Sandra
  3. Cell reports. 2020, Dec 22; 33(12): 108527.
  1. 4.   New insights into structural and functional relationships between LonA proteases and ClpB chaperones
  2. Rotanova, Tatyana V; Andrianova, Anna G; Kudzhaev, Arsen M; Li,Mi; Botos, Istvan; Wlodawer,Alexander; Gustchina,Alla
  3. FEBS open bio. 2019, JUL 21;
  1. 5.   Amylin-Abeta oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease
  2. Baram, M.; Atsmon-Raz, Y.; Ma, B.; Nussinov, R.; Miller, Y.
  3. Physical chemistry chemical physics : PCCP. 2016, 28-Jan; 18(4): 2330-8.
  1. 6.   A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth
  2. Chen, D. Y.; Lee, Y.; Van Tine, B. A.; Searleman, A. C.; Westergard, T. D.; Liu, H.; Tu, H. C.; Takeda, S.; Dong, Y. Y.; Piwnica-Worms, D. R.; Oh, K. J.; Korsmeyer, S. J.; Hermone, A.; Gussio, R.; Shoemaker, R. H.; Cheng, E. H. Y.; Hsieh, J. J. D.
  3. Cancer Research. 2012, Feb; 72(3): 736-746.
  1. 7.   Transgenic Mouse Model Expressing the Caspase 6 Fragment of Mutant Huntingtin
  2. Waldron-Roby, E.; Ratovitski, T.; Wang, X. F.; Jiang, M. L.; Watkin, E.; Arbez, N.; Graham, R. K.; Hayden, M. R.; Hou, Z. P.; Mori, S.; Swing, D.; Pletnikov, M.; Duan, W. Z.; Tessarollo, L.; Ross, C. A.
  3. Journal of Neuroscience. 2012, Jan; 32(1): 183-193.
  1. 8.   Protein structure prediction using a docking-based hierarchical folding scheme
  2. Kifer, I.; Nussinov, R.; Wolfson, H. J.
  3. Proteins-Structure Function and Bioinformatics. 2011, Jun; 79(6): 1759-1773.
  1. 9.   Premature death and neurologic abnormalities in transgenic mice expressing a mutant huntingtin exon-2 fragment
  2. Tebbenkamp, A. T. N.; Swing, D.; Tessarollo, L.; Borchelt, D. R.
  3. Human Molecular Genetics. 2011, Apr; 20(8): 1633-1642.
  1. 10.   Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor
  2. Zhang, M. Y.; Feng, Y.; Wang, Y.; Dimitrov, D. S.
  3. Mabs. 2009, Sep-Oct; 1(5): 475-80.
  1. 11.   Engineered Human Antibody Constant Domains with Increased Stability
  2. Gong, R.; Vu, B. K.; Feng, Y.; Prieto, D. A.; Dyba, M. A.; Walsh, J. D.; Prabakaran, P.; Veenstra, T. D.; Tarasov, S. G.; Ishima, R.; Dimitrov, D. S.
  3. Journal of Biological Chemistry. 2009 284(21): 14203-14210.
  1. 12.   Recombineering: a homologous recombination-based method of genetic engineering
  2. Sharan, S. K.; Thomason, L. C.; Kuznetsov, S. G.; Court, D. L.
  3. Nature Protocols. 2009 4(2): 206-223.
  1. 13.   Constructing templates for protein structure prediction by simulation of protein folding pathways
  2. Kifer, I.; Nussinov, R.; Wolfson, H. J.
  3. Proteins-Structure Function and Bioinformatics. 2008 73(2): 380-394.
  1. 14.   Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-I
  2. Giomarelli, B.; Washington, V. A.; Chisholm, M. M.; Quigley, L.; McMahon, J. B.; Mori, T.; McVicar, D. W.
  3. Thrombosis and Haemostasis. 2007, Jun; 97(6): 955-964.
  1. 15.   In vitro efficacy of immuno-chemotherapy with anti-EGFR human fab-taxol conjugate on A431 epidermoid carcinoma cells
  2. Wang, X.; Zhu, J.; Zhao, P.; Jiao, Y. G.; Xu, N.; Grabinski, T.; Liu, C.; Miranti, C. K.; Fu, T.; Cao, B. B.
  3. Cancer Biology & Therapy. 2007, Jun; 6(6): 980-986.
  1. 16.   Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization
  2. Herrmann, J. E.; Wang, S. X.; Zhang, C. Y.; Panchal, R. G.; Bavari, S.; Lyons, C. R.; Lovchik, J. A.; Golding, B.; Shiloach, J.; Lu, S.
  3. Vaccine. 2006, Jul; 24(31-32): 5872-5880.
  1. 17.   Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin
  2. Tanaka, Y.; Igarashi, S.; Nakamura, M.; Gafni, J.; Torcassi, C.; Schilling, G.; Crippen, D.; Wood, J. D.; Sawa, A.; Jenkins, N. A.; Copeland, N. G.; Borchelt, D. R.; Ross, C. A.; Ellerby, L. M.
  3. Neurobiology of Disease. 2006, FEB; 21(2): 381-391.
  1. 18.   Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells
  2. Kim, B. J.; Hood, B. L.; Aragon, R. A.; Hardwick, J. R.; Conrads, T. R.; Veenstra, T. D.; Song, B. J.
  3. Proteomics. 2006, FEB; 6(4): 1250-1260.
  1. 19.   Molecular architecture and ligand recognition determinants for T4 RNA ligase
  2. El Omari, K.; Ren, J.; Bird, L. E.; Bona, M. K.; Klarmann, G.; Legrice, S. F. J.; Stammers, D. K.
  3. Journal of Biological Chemistry. 2006, JAN 20; 281(3): 1573-1579.
  1. 20.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 21.   Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus
  2. Hibbert, C. S.; Rein, A.
  3. Journal of Virology. 2005, JUL; 79(13): 8142-8148.
  1. 22.   Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5 '-phosphate complex reveals a new binding site for a nucleotide inhibitor
  2. Williams, K. L.; Zhang, Y. J.; Shkriabai, N.; Karki, R. G.; Nicklaus, M. C.; Kotrikadze, N.; Hess, S.; Le Grice, S. F. J.; Craigie, R.; Pathak, V. K.; Kvaratskhelia, M.
  3. Journal of Biological Chemistry. 2005, MAR 4; 280(9): 7949-7955.
  1. 23.   Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter
  2. Kuzmin, I.; Geil, L.; Gibson, L.; Cavinato, T.; Loukinov, D.; Lobanenkov, V.; Lerman, M. I.
  3. Journal of Molecular Biology. 2005, FEB 18; 346(2): 411-422.
  1. 24.   Importance of communication between producers and consumers of publicly available experimental data
  2. Liotta, L. A.; Lowenthal, M.; Mehta, A.; Conrads, T. P.; Veenstra, T. D.; Fishman, D. A.; Petricoin, E. F.
  3. Journal of the National Cancer Institute. 2005, FEB 16; 97(4): 310-314.
  1. 25.   Multiple docking for protein structure prediction
  2. Inbar, Y.; Wolfson, H. J.; Nussinov, R.
  3. International Journal of Robotics Research. 2005, FEB-MAR; 24(2-3): 131-150.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel